Improving quality in nanoparticle-induced cytotoxicity testing by a tiered inter-laboratory comparison study

Inge Nelissen, Andrea Haase, Sergio Anguissola, Louise Rocks, An Jacobs, Hanny Willems, Christian Riebeling, Andreas Luch, Jean Pascal Piret, Olivier Toussaint, Bénédicte Trouiller, Ghislaine Lacroix, Arno C. Gutleb, Servane Contal, Silvia Diabaté, Carsten Weiss, Tamara Lozano-Fernández, África González-Fernández, Maria Dusinska, Anna HukVicki Stone, Nilesh Kanase, Marek Nocuń, Maciej Stępnik, Stefania Meschini, Maria Grazia Ammendolia, Nastassja Lewinski, Michael Riediker, Marco Venturini, Federico Benetti, Jan Topinka, Tana Brzicova, Silvia Milani, Joachim Rädler, Anna Salvati, Kenneth A. Dawson

Research output: Contribution to journalArticle

Abstract

The quality and relevance of nanosafety studies constitute major challenges to ensure their key role as a supporting tool in sustainable innovation, and subsequent competitive economic advantage. However, the number of apparently contradictory and inconclusive research results has increased in the past few years, indicating the need to introduce harmonized protocols and good practices in the nanosafety research community. Therefore, we aimed to evaluate if best-practice training and inter-laboratory comparison (ILC) of performance of the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay for the cytotoxicity assessment of nanomaterials among 15 European laboratories can improve quality in nanosafety testing. We used two well-described model nanoparticles, 40-nm carboxylated polystyrene (PS-COOH) and 50-nm amino-modified polystyrene (PS-NH2). We followed a tiered approach using well-developed standard operating procedures (SOPs) and sharing the same cells, serum and nanoparticles. We started with determination of the cell growth rate (tier 1), followed by a method transfer phase, in which all laboratories performed the first ILC on the MTS assay (tier 2). Based on the outcome of tier 2 and a survey of laboratory practices, specific training was organized, and the MTS assay SOP was refined. This led to largely improved intra-and inter-laboratory reproducibility in tier 3. In addition, we confirmed that PS-COOH and PS-NH2 are suitable negative and positive control nanoparticles, respectively, to evaluate impact of nanomaterials on cell viability using the MTS assay. Overall, we have demonstrated that the tiered process followed here, with the use of SOPs and representative control nanomaterials, is necessary and makes it possible to achieve good inter-laboratory reproducibility, and therefore high-quality nanotoxicological data.

Original languageEnglish
Article number1430
Pages (from-to)1-20
Number of pages20
JournalNanomaterials
Volume10
Issue number8
DOIs
Publication statusPublished - Aug 2020

Keywords

  • Best practice
  • Cytotoxicity
  • Inter-laboratory comparison
  • nanosafety
  • Training

Fingerprint Dive into the research topics of 'Improving quality in nanoparticle-induced cytotoxicity testing by a tiered inter-laboratory comparison study'. Together they form a unique fingerprint.

  • Cite this

    Nelissen, I., Haase, A., Anguissola, S., Rocks, L., Jacobs, A., Willems, H., Riebeling, C., Luch, A., Piret, J. P., Toussaint, O., Trouiller, B., Lacroix, G., Gutleb, A. C., Contal, S., Diabaté, S., Weiss, C., Lozano-Fernández, T., González-Fernández, Á., Dusinska, M., ... Dawson, K. A. (2020). Improving quality in nanoparticle-induced cytotoxicity testing by a tiered inter-laboratory comparison study. Nanomaterials, 10(8), 1-20. [1430]. https://doi.org/10.3390/nano10081430